<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Streed CG</submitter><funding>American Heart Association</funding><funding>Doris Duke Charitable Foundation</funding><funding>American Heart Association-American Stroke Association</funding><funding>National Heart, Lung, and Blood Institute</funding><funding>NHLBI NIH HHS</funding><funding>Boston University Chobanian and Avedisian School of Medicine Department of Medicine Career Investment</funding><pagination>1047-1055</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10198536</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>30(6)</volume><pubmed_abstract>&lt;h4>Objective&lt;/h4>To adapt and validate an algorithm to ascertain transgender and gender diverse (TGD) patients within electronic health record (EHR) data.&lt;h4>Methods&lt;/h4>Using a previously unvalidated algorithm of identifying TGD persons within administrative claims data in a multistep, hierarchical process, we validated this algorithm in an EHR data set with self-reported gender identity.&lt;h4>Results&lt;/h4>Within an EHR data set of 52 746 adults with self-reported gender identity (gold standard) a previously unvalidated algorithm to identify TGD persons via TGD-related diagnosis and procedure codes, and gender-affirming hormone therapy prescription data had a sensitivity of 87.3% (95% confidence interval [CI] 86.4-88.2), specificity of 98.7% (95% CI 98.6-98.8), positive predictive value (PPV) of 88.7% (95% CI 87.9-89.4), and negative predictive value (NPV) of 98.5% (95% CI 98.4-98.6). The area under the curve (AUC) was 0.930 (95% CI 0.925-0.935). Steps to further categorize patients as presumably TGD men versus women based on prescription data performed well: sensitivity of 97.6%, specificity of 92.7%, PPV of 93.2%, and NPV of 97.4%. The AUC was 0.95 (95% CI 0.94-0.96).&lt;h4>Conclusions&lt;/h4>In the absence of self-reported gender identity data, an algorithm to identify TGD patients in administrative data using TGD-related diagnosis and procedure codes, and gender-affirming hormone prescriptions performs well.</pubmed_abstract><journal>Journal of the American Medical Informatics Association : JAMIA</journal><pubmed_title>Validation of an administrative algorithm for transgender and gender diverse persons against self-report data in electronic health records.</pubmed_title><pmcid>PMC10198536</pmcid><funding_grant_id>K01 HL151902</funding_grant_id><funding_grant_id>R01HL141434</funding_grant_id><funding_grant_id>R01HL092577</funding_grant_id><funding_grant_id>2022061</funding_grant_id><funding_grant_id>NHLBI 1K01HL151902-01A1</funding_grant_id><funding_grant_id>R01 HL092577</funding_grant_id><funding_grant_id>AHA 20CDA35320148</funding_grant_id><funding_grant_id>R01 HL141434</funding_grant_id><funding_grant_id>AHA_18SFRN34110082</funding_grant_id><pubmed_authors>Paasche-Orlow MK</pubmed_authors><pubmed_authors>Streed CG</pubmed_authors><pubmed_authors>Jasuja GK</pubmed_authors><pubmed_authors>King D</pubmed_authors><pubmed_authors>Tangpricha V</pubmed_authors><pubmed_authors>Grasso C</pubmed_authors><pubmed_authors>Poteat T</pubmed_authors><pubmed_authors>Mukherjee M</pubmed_authors><pubmed_authors>Shapira-Daniels A</pubmed_authors><pubmed_authors>Cabral H</pubmed_authors><pubmed_authors>Reisner SL</pubmed_authors><pubmed_authors>Mayer KH</pubmed_authors><pubmed_authors>Benjamin EJ</pubmed_authors></additional><is_claimable>false</is_claimable><name>Validation of an administrative algorithm for transgender and gender diverse persons against self-report data in electronic health records.</name><description>&lt;h4>Objective&lt;/h4>To adapt and validate an algorithm to ascertain transgender and gender diverse (TGD) patients within electronic health record (EHR) data.&lt;h4>Methods&lt;/h4>Using a previously unvalidated algorithm of identifying TGD persons within administrative claims data in a multistep, hierarchical process, we validated this algorithm in an EHR data set with self-reported gender identity.&lt;h4>Results&lt;/h4>Within an EHR data set of 52 746 adults with self-reported gender identity (gold standard) a previously unvalidated algorithm to identify TGD persons via TGD-related diagnosis and procedure codes, and gender-affirming hormone therapy prescription data had a sensitivity of 87.3% (95% confidence interval [CI] 86.4-88.2), specificity of 98.7% (95% CI 98.6-98.8), positive predictive value (PPV) of 88.7% (95% CI 87.9-89.4), and negative predictive value (NPV) of 98.5% (95% CI 98.4-98.6). The area under the curve (AUC) was 0.930 (95% CI 0.925-0.935). Steps to further categorize patients as presumably TGD men versus women based on prescription data performed well: sensitivity of 97.6%, specificity of 92.7%, PPV of 93.2%, and NPV of 97.4%. The AUC was 0.95 (95% CI 0.94-0.96).&lt;h4>Conclusions&lt;/h4>In the absence of self-reported gender identity data, an algorithm to identify TGD patients in administrative data using TGD-related diagnosis and procedure codes, and gender-affirming hormone prescriptions performs well.</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 May</publication><modification>2026-06-03T21:31:46.344Z</modification><creation>2025-07-12T03:04:16.081Z</creation></dates><accession>S-EPMC10198536</accession><cross_references><pubmed>36921287</pubmed><doi>10.1093/jamia/ocad039</doi></cross_references></HashMap>